An open-label study of a new formulation of Viracept [nelfinavir] to assess gastrointestinal tolerability in patients with HIV-1 infection.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Nelfinavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 23 Feb 2010 Last checked against Roche record.
- 23 Jun 2006 New trial record.